Zimmer Biomet Holdings Inc

ZBH

Add to Watchlist

83.725USD

+0.355+0.43%

Market hours （ET）Quotes delayed by 15 min

Zimmer Biomet Holdings Inc's Score

Industry at a Glance

Industry Ranking

30 / 206

Overall Ranking

111 / 4490

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Zimmer Biomet Holdings Inc Highlights

StrengthsRisks

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 21.51%.

Undervalued

The company’s latest PE is 21.56, at a low 3-year percentile range.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 879.00 shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.42.

Analyst Rating

Based on 31 analysts

Hold

Current Rating

98.700

Target Price

+19.88%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Zimmer Biomet Holdings Inc is 8.52, ranking 27 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 2.09B, representing a year-over-year increase of 9.30%, while its net profit experienced a year-over-year increase of 30.82%.

Score

Industry at a Glance

Previous score

8.52

Change

0



Financials

6.47

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.47

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.31

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.35

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Zimmer Biomet Holdings Inc is 7.64, ranking 71 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 21.56, which is 450.14% below the recent high of 118.60 and 10.30% above the recent low of 19.34.

Score

Industry at a Glance

Previous score

7.64

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 30/206

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Zimmer Biomet Holdings Inc is 6.47, ranking 168 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 100.00, with a high of 125.00 and a low of 88.00.

Score

Industry at a Glance

Previous score

6.47

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Zimmer Biomet Holdings Inc is 6.97, ranking 84 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 93.65 and the support level at 76.10, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.57

Change

0.4

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-05-12

The current institutional shareholding score of Zimmer Biomet Holdings Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 101.82%, representing a quarter-over-quarter decrease of 3.74%. The largest institutional shareholder is Van Duyn Dodge & E. Morris Cox, holding a total of 23.51M shares, representing 12.15% of shares outstanding, with 22.91% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Dodge & Cox

Star Investors

23.51M

+1.25%

T. Rowe Price Associates, Inc.

Star Investors

13.34M

-9.74%

Harris Associates L.P.

Star Investors

12.26M

+158.17%

BlackRock Institutional Trust Company, N.A.

11.02M

-0.35%

State Street Investment Management (US)

8.83M

+2.26%

Capital International Investors

7.13M

-5.60%

Geode Capital Management, L.L.C.

5.23M

+0.70%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Zimmer Biomet Holdings Inc is 7.50, ranking 38 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.47. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Zimmer Biomet Holdings Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Zimmer Biomet Holdings Inc

ZBH

7.71 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Lantheus Holdings Inc

LNTH

8.76 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Anika Therapeutics Inc

ANIK

8.57 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.42 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.39 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Bruker Corp

BRKR

8.30 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment